Clinical Trials Logo

Choroid Neoplasms clinical trials

View clinical trials related to Choroid Neoplasms.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT00406120 Withdrawn - Uveal Neoplasms Clinical Trials

Validation of a Molecular Prognostic Test for Eye Melanoma

Start date: May 2007
Phase:
Study type: Observational

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detected by gene expression profiling and accurately predict which patients will develop metastasis. This molecular test could eventually allow high risk patients to receive preventative therapy to delay or prevent the development of metastasis. The goal of this study is to prospectively validate the predictive accuracy of the gene expression-based molecular test and compare it to monosomy 3, the most common but potentially less accurate molecular marker for metastasis in ocular melanoma.